Search

Meet Globalfinanz, our new ally. We talked to Begoña Torregrosa, partner and head of Collectives.

In recent years, Spain has achieved significant progress that has improved its ability to attract innovative talent, although many barriers still persist. We analyze the situation with LIM Global

From AseBio, we have analyzed the program of the Spanish Presidency and where R&D and biotechnology would be present, with the mission of identifying points on which we can have an impact and work

The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM) celebrating its 1st conference on the cellular secretome to highlight the potential of this pathway

Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial based on positive safety data from the initial 167 randomized patients.

Meet Binit Tech, our new ally. We talked to Leandro Harillo, Technology Director.

Meet Zeta GmbH, our new member. We talked to Andreas Marchler, CEO of the company and with Christine Kolland, Business Development in Spain.

Meet Bexen Medical, our new member. We talked to Manuel Sánchez-Lagarejo, CEO of the company.

Meet r Multipartner Virtual Data Room, our new member. We talked to María del Mar García, Area Manager Spain & LatAm at the company

Precision medicine has brought about a real revolution in the treatment of some diseases such as cancer. We analyze the latest advances from Promega, Silver Sponsor of BIOSPAIN 2023.

All resolutions were approved and 35% of the issued shares represented.

This collaboration allows combining experience and resources for the discovery and development of new therapies.

During the Presidency of the Council of the European Union, Spain will lead the dialogue on these critical policies for European patients, food safety, and the green transition.

This new location of GENESIS Biomed in the BioHub joins the existing locations in Barcelona and Madrid.

Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures.

Meet KINSY our new member. We talked to Alicia Hernández, Projects and Business Development Coordinator of the company.

Comprehensively reversed disease progression symptoms in a CMT mice model.

The results from APRIL study, previously presented at the International Stroke Conference 2023, indicate that ApTOLL showed good safety in 151 acute ischemic stroke patients.

In 2021, the impact on GDP of biotech companies amounted to €11,183 million, or 1% of GDP

On European Skin Cancer Prevention Day, we talk to Almirall, Platinum Sponsor of BIOSPAIN2023, about the importance of prevention and the main risk factors

ZIP Solutions (Barcelona), a 100% affiliate of Biat Group (ticker BST), and YIMA, a Cyagen-owned AI-enabled biotech company, are please to announce a strategic co-marketing agreement for gene therapy.